OD
ODYY.US Odyssey Group International Inc
- Market cap
- USD 827K
- P/E
- -
- P/B
- 0.38x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jul 2026.
Is ODYY.US undervalued?
Graham numberThe Graham number of Odyssey Group International Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Odyssey Group International Inc fundamental analysis
No fundamental analysis for Odyssey Group International Inc yet.
Odyssey Group International Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Odyssey Group International Inc
Odyssey Health, Inc., a medical company, focuses on the development and acquisition of medical products and health related technologies. The company develops CardioMap, a heart monitoring and screening device; develops or acquires medical-related products; and Save A Life choking rescue devices. Its product candidates include ONP-002 for the treatment of mild brain trauma or concussion and the delivery device. The company was formerly known as Odyssey Group International, In…
Full company profileOdyssey Group International Inc financial statements
Odyssey Group International Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 266K | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 |
| Gross Profit | -10.6K | -10.6K | -10.6K | 256K | -5.55K | -2.37K | -3.42K | - | - | - |
| Operating Income | -168K | -420K | -378K | -3.85M | -15.9M | -8.11M | -5.31M | 14.3M | -1.02M | -913K |
| EBITDA | -157K | -410K | -23.3M | -3.84M | -15.8M | -7.61M | -5.30M | -2.14M | -1.44M | -913K |
| Net Income | -198K | -483K | -519K | -4.35M | -16.9M | -8.44M | -5.92M | -906K | -1.74M | -5.73M |
| EPS | 0.00 | 0.00 | -0.01 | -0.05 | -0.18 | -0.09 | -0.07 | -0.01 | -0.02 | -0.05 |
| Balance Sheet | ||||||||||
| Total Assets | 159K | 27.5K | 23.7M | 106K | 611K | 570K | 456K | 586K | 49.7K | 148K |
| Total Liabilities | 579K | 847K | 1.27M | 757K | 3.38M | 5.21M | 6.61M | 5.92M | 7.00M | 12.3M |
| Shareholders' Equity | -420K | -819K | 22.4M | -651K | -2.77M | -4.64M | -6.16M | -5.33M | -6.95M | -12.1M |
| Cash & Short-term Investments | 13.4K | 390.00 | 167K | 63.0K | 557K | 72.5K | 36.9K | 2.38K | 19.1K | 122K |
| Total Debt | 433K | 632K | 785K | 276K | 736K | 1.53M | 2.14M | 1.65M | 1.98M | 3.07M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -117K | -146K | -105K | -649K | -3.42M | -3.18M | -1.47M | -1.22M | -347K | -1.05M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 45.2K | 10.1K | 0.00 | 0.00 | 3.00 |
| Free Cash Flow | -117K | -146K | -105K | -649K | -3.42M | -3.22M | -1.48M | -1.22M | -347K | -1.05M |
| Ratios | ||||||||||
| ROE | - | - | -2.3% | - | - | - | - | - | - | - |
| ROA | -124.2% | -1,759.4% | -2.2% | -4,118.9% | -2,765.3% | -1,482.3% | -1,298.7% | -154.5% | -3,504.8% | -3,875.1% |
| Net Profit Margin | - | - | - | -1,633.9% | - | - | - | - | - | - |
| Debt to Equity | - | - | 0.04x | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Odyssey Group International Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | USD 63.5K | 0.00 | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Odyssey Group International Inc
- Insiders 14.37%
- Institutions 0.00%
- Public & others 85.63%
- Shares outstanding 110M
- Free float 94.4M
Odyssey Group International Inc company profile
- Company name
- Odyssey Group International Inc
- Ticker
- ODYY.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 2
- Fiscal year end
- July
- Address
- 2300 West Sahara Avenue, Las Vegas, NV, United States, 89102
- Phone
- 702 780 6559
- Website
- odysseyhealthinc.com
About Odyssey Group International Inc
Odyssey Health, Inc., a medical company, focuses on the development and acquisition of medical products and health related technologies. The company develops CardioMap, a heart monitoring and screening device; develops or acquires medical-related products; and Save A Life choking rescue devices. Its product candidates include ONP-002 for the treatment of mild brain trauma or concussion and the delivery device. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.
Odyssey Group International Inc management
3- Mr. Joseph Michael RedmondChairman, President & CEO · born 1961
- Ms. Christine M. FarrellCFO & Secretary · born 1960
- Mr. Michael ContarinoHead of Product Development · born 1955